Table 2.
Adjusted Odds Ratios for Prevalence, Management, and Control of Diabetes and Related Comorbid Conditions
| Crude Prevalence, n (%) | Adjusted Odds Ratios (95% CI) | ||
|---|---|---|---|
| Internet Users (N=308) | Internet Nonusers (N=588) | ||
| Coronary artery disease | 73 (24) | 237 (40) | 1.3 (0.9 to 1.9) |
| Peripheral vascular disease | 25 (8) | 103 (18) | 1.7 (0.99 to 3.0) |
| Heart failure | 19 (6) | 96 (16) | 1.6 (0.9 to 3.0) |
| COPD | 42 (14) | 114 (19) | 1.3 (0.8 to 2.0) |
| Oral hypoglycemic therapy | 137 (45) | 284 (48) | 1.2 (0.9 to 1.7) |
| Any insulin therapy | 66 (21) | 173 (29) | 1.3 (0.9 to 2.0) |
| Hemoglobin A1c<7.0 | 125 (41) | 260 (45) | 1.0 (0.7 to 1.4) |
| Hypertension | 263 (85) | 537 (91) | 0.8 (0.4 to 1.3) |
| Antihypertensive therapy | 134 (44) | 348 (59) | 1.0 (0.7 to 1.5) |
| Blood pressure<130/80 mm Hg | 88 (33) | 144 (27) | 1.3 (0.9 to 2.0) |
| Hyperlipidemia | 226 (73) | 448 (76) | 1.0 (0.7 to 1.5) |
| Lipid-lowering therapy | 71 (23) | 31.8 (32) | 1.1 (0.7 to 1.6) |
| LDL<100 mg/dl (SD) | 157 (54) | 356 (64) | 0.7 (0.5 to 0.99)* |
Numbers are means and standard deviations, or number and column percent; Adjusted odds ratios are for Internet nonusers compared to users, adjusted for age, insurance status, and level of education.
*
P<.05.
SD, standard deviation; COPD, chronic obstructive pulmonary disease; LDL, low-density lipoprotein cholestrol